Skip to main content

This website is no longer being updated. Visit Dartmouth Now for all news published after June 7, 2010.


Dartmouth News
>  Features >   Views from the Green >   2010

Views from the Green

New vaccine effective in preventing TB in African patients with HIV infection

Fordham von Reyn
Fordham von Reyn

Recorded January 26, 2010

Investigators from Dartmouth Medical School (DMS) have reported results of a clinical trial showing that a new vaccine against tuberculosis, Mycobacterium vaccae (MV), is effective in preventing tuberculosis in people with HIV infection. The DarDar Health Study, named for Dartmouth and Dar es Salaam, Tanzania, found that MV immunization reduced the rate of definite tuberculosis by 39 percent among 2,000 HIV-infected patients in Tanzania. Principal Investigator Ford von Reyn, M.D., director of the DarDar International Programs for the Section on Infectious Disease and International Health at DMS discusses the development of the vaccine.

Related links:

Last Updated: 2/23/10